Trial intelligence / Profile preview

Phase 2 single-arm study of dacomitinib with or without dose titration in EGFR-mutant advanced NSCLC

KCT0005223Phase 2Not yet recruiting

Sponsor

National Cancer Centre Singapore

Start

Aug 2020

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1